Knight Cancer Institute
PORTLAND, Ore. – Speakers who nominally represent cancer patients at advisory meetings on new drugs often have financial ties with the company seeking marketing approval. And those ties aren't always disclosed, according to an analysis appearing inJAMA Internal Medicine.
PORTLAND, Ore. – An analysis of media coverage published in JAMA Oncology finds that the use of superlative terms to describe new cancer drugs is commonplace even when the drugs show only modest benefits or there is still a lack of clinical data to support enthusiastic statements.
PORTLAND, Ore.– The Knight Cancer Institute at Oregon Health & Science University (OHSU) is seeking grant applicants statewide to receive funding through a program dedicated to supporting community-specific projects that meet cancer-related needs.
Willamette Dental Group, the Pacific Northwest’s largest multispecialty group dental practice, has committed to fighting cancer head-on by pledging $1 million to Oregon Health & Science University’s Knight Cancer Challenge.
May 8, 2013 -- A day after the Food and Drug Administration proposed new warning labels about the risk of cancer from tanning beds, the Oregon Legislature moved closer to banning commercial tanning salons from serving customers younger than 18.
April 5, 2013 -- The tanning lobby won a major concession today in the Senate Health Committee, which voted to scale back a ban on carcinogenic tanning beds for minors.
February 29, 2012 -- Oregon Health & Science University's Knight Cancer Institute and Legacy Health's Cancer Institute have signed a letter of intent to expand upon their existing collaboration to deliver the most advanced community adult cancer care at all of their mutual locations.